Acquired Long QT Syndrome after Acute Myocardial Infarction: A Rare but Potentially Fatal Entity.


Journal

Texas Heart Institute journal
ISSN: 1526-6702
Titre abrégé: Tex Heart Inst J
Pays: United States
ID NLM: 8214622

Informations de publication

Date de publication:
01 04 2020
Historique:
entrez: 1 7 2020
pubmed: 1 7 2020
medline: 1 9 2021
Statut: ppublish

Résumé

Acquired long QT syndrome is typically caused by medications, electrolyte disturbances, bradycardia, or catastrophic central nervous system events. We report a case of myocardial infarction-related acquired long QT syndrome in a 58-year-old woman that had no clear cause and progressed to torsades de pointes requiring treatment with isoproterenol and magnesium. Despite negative results of DNA testing against a known panel of genetic mutations and polymorphisms associated with long QT syndrome, the patient's family history of fatal cardiac disease suggests a predisposing genetic component. This report serves to remind clinicians of this potentially fatal ventricular arrhythmia after myocardial infarction.

Identifiants

pubmed: 32603470
pii: 438358
doi: 10.14503/THIJ-18-6872
pmc: PMC7328093
doi:

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

163-164

Subventions

Organisme : NHLBI NIH HHS
ID : K08 HL133491
Pays : United States

Informations de copyright

© 2020 by the Texas Heart® Institute, Houston.

Références

J Am Coll Cardiol. 2001 Oct;38(4):1168-74
pubmed: 11583899
Heart Rhythm. 2012 Jul;9(7):1104-12
pubmed: 22338672
Pacing Clin Electrophysiol. 2018 Apr;41(4):414-421
pubmed: 29405316
Eur Heart J. 1985 Nov;6 Suppl D:85-95
pubmed: 2417855
J Am Coll Cardiol. 1994 Jan;23(1):259-77
pubmed: 8277090
Circulation. 1991 Apr;83(4):1352-60
pubmed: 2013152

Auteurs

Samuel S Gordon (SS)

Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, California 90025.

John Hollowed (J)

Division of Cardiology, David Geffen School of Medicine at UCLA, Los Angeles, California 90025.

Justin Hayase (J)

Division of Cardiology, David Geffen School of Medicine at UCLA, Los Angeles, California 90025.

Carlos Macias (C)

Division of Cardiology, David Geffen School of Medicine at UCLA, Los Angeles, California 90025.

Jessica Wang (J)

Division of Cardiology, David Geffen School of Medicine at UCLA, Los Angeles, California 90025.

Holly R Middlekauff (HR)

Division of Cardiology, David Geffen School of Medicine at UCLA, Los Angeles, California 90025.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH